Summit Trail Advisors, LLC Puma Biotechnology, Inc. Transaction History

Summit Trail Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$20.07 - $46.7 $67,314 - $156,631	-3,354 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $65,384 - $94,981	1,587 Added 89.81%	3,354 $154,000
Q2 2018 Aug 10, 2018	SELL	$48.3 - $68.25 $285,163 - $402,948	-5,904 Reduced 76.97%	1,767 $105,000
Q1 2018 May 22, 2018	SELL	$59.7 - $99.25 $17.9 Million - $29.7 Million	-299,139 Reduced 97.5%	7,671 $307,000
Q1 2018 May 21, 2018	BUY	$59.7 - $99.25 $18 Million - $29.9 Million	301,180 Added 5349.56%	306,810 $307,000
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $528,375 - $745,693	5,630	5,630 $383,000

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.